Improving the Quality of Care for Adults With Inflammatory Bowel Disease
IBD:QORUS
2 other identifiers
observational
10,000
1 country
29
Brief Summary
Innovative programs exist that suggest that care for people with chronic conditions is optimized when patients and providers have the information they need at the point of care and over time, to engage in shared planning and execution of treatment goals and care plans. This project aims to build an Inflammatory Bowel Disease Learning Health System, a shared information environment, that highlights collaboration among patients, clinicians and care team members, and researchers; for effective use of data for guiding care, value, improvement, and research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2016
Longer than P75 for all trials
29 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 26, 2016
CompletedFirst Submitted
Initial submission to the registry
May 13, 2016
CompletedFirst Posted
Study publicly available on registry
June 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
August 21, 2025
August 1, 2025
14.8 years
May 13, 2016
August 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients enrolled
count of number of patients consented
annually, up to 5 years
Secondary Outcomes (6)
Proportion of patients in remission
annually, up to 5 years
Proportion of patients on steroids
annually, up to 5 years
Proportion of patients admitted into the Emergency Room
annually, up to 5 years
Proportion of patients hospitalized
annually, up to 5 years
Proportion of patients with anemia
annually, up to 5 years
- +1 more secondary outcomes
Study Arms (1)
Registry participant
This is a registry study, the same information is collected from all participants.
Eligibility Criteria
In order to participate in IBD Qorus, individuals must meet the following criteria: * 18 years of age or older * Diagnosis of Crohn's disease or ulcerative colitis or IBD unclassified * Accept the terms and conditions of Informed Consent and Authorization * Affiliated with a participating IBD Qorus site
You may qualify if:
- years of age or older
- Diagnosis of Crohn's disease or ulcerative colitis or IBD unclassified
- Accept the terms and conditions of Informed Consent and Authorization
- Affiliated with a participating IBD Qorus site
You may not qualify if:
- Inability to provide informed consent
- Study key personnel cannot enroll as a study participant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dartmouth-Hitchcock Medical Centerlead
- Crohn's and Colitis Foundationcollaborator
- Cedars-Sinai Medical Centercollaborator
- Dartmouth Collegecollaborator
Study Sites (29)
Cedars-Sinai Inflammatory Bowel Disease Center
Los Angeles, California, 90048, United States
Hoag Digestive Health
Newport Beach, California, 92658, United States
UC San Diego Health Inflammatory Bowel Disease Center
San Diego, California, 92037, United States
University of Colorado Health
Denver, Colorado, 80045, United States
Yale School of Medicine IBD Program
New Haven, Connecticut, 06520, United States
MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease
Washington D.C., District of Columbia, 20007, United States
Gastro Health LLC
Miami, Florida, 33133, United States
University of South Florida
Tampa, Florida, 33606, United States
Atlanta Gastroenterology Associates
Atlanta, Georgia, 30342, United States
Digestive Health Center
Boise, Idaho, 83704, United States
University of Chicago Medicine Inflammatory Bowel Disease Center
Chicago, Illinois, 60637, United States
Digestive Care Center
Evansville, Indiana, 47714, United States
GastroIntestinal Specialists, A.M.C.
Shreveport, Louisiana, 71115, United States
Corewell Health
Grand Rapids, Michigan, 49546, United States
Dartmouth-Hitchcock Inflammatory Bowel Disease Center
Lebanon, New Hampshire, 03756, United States
Saratoga Schenectady Gastroenterology Associates
Burnt Hills, New York, 12027, United States
NYU Long Island- Inflammatory Bowel Disease Center
Mineola, New York, 11501, United States
New York University Langone Medical Center
New York, New York, 10016, United States
Weill Cornell Medical College
New York, New York, 10065, United States
University of Rochester
Rochester, New York, 14642, United States
The Oregon Clinic - Gastroenterology
Portland, Oregon, 97220, United States
Penn State Hershey Inflammatory Bowel Disease Center
Hershey, Pennsylvania, 17033, United States
Regional GI
Lancaster, Pennsylvania, 17601, United States
Gastroenterology Associates
Providence, Rhode Island, 02904, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Baylor College of Medicine IBD Center
Houston, Texas, 77030, United States
University of Utah Health Care
Salt Lake City, Utah, 84132, United States
University of Virginia
Charlottesville, Virginia, 22903, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Corey Siegel, MD, MS
Dartmouth-Hitchcock Medical Center
- PRINCIPAL INVESTIGATOR
Gil Melmed, MD, MS
Cedars-Sinai Medical Center
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 20 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Section Chief, Section of Gastroenterology
Study Record Dates
First Submitted
May 13, 2016
First Posted
June 7, 2016
Study Start
February 26, 2016
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
August 21, 2025
Record last verified: 2025-08